期刊文献+

重组腺相关病毒介导的PD-L1基因在大鼠移植肝中的表达

Expression of PD-L1 gene mediated by recombinant adeno-associated virus 2 in rat liver allograft
下载PDF
导出
摘要 目的探讨供肝转染PD-L1-AAV2-RFP后基因的表达情况。方法近交系BN大鼠随机分3组:同基因肝移植组(ISO组)、腺相关病毒空载体组(AAV组)、基因转染组(PD-L1组),每组6对。ISO组供肝冷保存期经门静脉注射生理盐水2mL,保存2h后采用改良"二袖套法"行原位肝移植;AAV、PD-L1组所用灌注液分别为AAV2-RFP空病毒颗粒和PD-L1-AAV2-RFP(1×1011v.g./只)。术后7、14d各取3只大鼠采血测定肝功能,取肝组织即刻行冰冻切片在荧光显微镜下观察RFP的表达,免疫组化染色法检测PD-L1蛋白的表达。结果3组术后7d谷丙转氨酶(ALT)、谷草转氨酶(AST)均明显增高,14d后基本恢复正常,各组间相比均无显著性差异(P>0.05);术后7d在荧光显微镜下AAV、PD-L1组移植肝可见少量而微弱的红色荧光,14d可见高亮度的红色荧光,而各组肝外组织及ISO组各时段均未见红色荧光;免疫组化染色结果示未转染组PD-L1蛋白均微弱表达,而PD-L1转染7d后随时间延长靶基因表达逐渐增强(P<0.05)。结论重组腺相关病毒介导,体外冷保存期经门静脉途径供肝转染PD-L1,可以使PD-L1基因在肝内获得安全、有效的表达。 Objective To investigate the transfection and expression of PD-L1-AAV2-RFP after rat liver transplantation. Methods All rats were divided into isogenie liver transplantation group (ISO group), liver transplantation group infected by AAV2-RFP (AAV group) and PD-L1-AAV2-RFP (PD-L1 group). Recombinant virus were respectively injected into portal vein and kept for 2 hours to transfect grafts during cold preservation in vitro. Three rats were killed on postoperative day 7 and 14 respectively. Serum samples were collected for decting liver function. Transgene expression of PD-L1 was assessed by means of fluorescent microscope and immunohistochemistry. Results Serum levels of ALT and AST increased obviously on the 7th day after transplantation, then gradually returned back to normal with time. The liver function of PD-L1 group was similar to those of ISO and AAV groups. Otherwise, the expression of RFP in PD-L1 group was significant higher than those of ISO and AAV groups observed by fluorescent microscope. The expression of PD-L1 protein was up-regulated in the liver of donor after transfection in PD-L1 group, but still lower in other groups. Conclusion During cold preservation in vitro through portal vein injection to donor liver, AAV mediated gene transfection can successfully achieve local gene expression.
出处 《免疫学杂志》 CAS CSCD 北大核心 2008年第6期678-680,683,共4页 Immunological Journal
基金 国家自然科学基金(30400418) 重庆市自然科学基金重点项目(CSTC,2005BA5004)资助
关键词 程序性死亡配体-1 腺相关病毒-2 肝移植 基因转染 大鼠 PD-L1 AAV2 Liver transplantation Gene transfection Rat
  • 相关文献

参考文献11

  • 1王儒鹏,何威,贺伟峰,张小容,刘树雷,吴军.重组免疫毒素对同种小鼠皮肤移植排斥反应的抑制作用[J].免疫学杂志,2008,24(3):308-310. 被引量:3
  • 2Wood K J, Prior TG. Gene therapy in transplantation [ J ]. Curr Opin Mol Ther, 2001, 3(4) : 390- 398.
  • 3Chen CH, Kuo LM, Chang Y, et al. In vivo immune modulatory activity of hepatic stellate cells in mice [ J ]. Hepatology, 2006, 44(5): 1 171- 1 181.
  • 4游捷,赵蓉,刘礼斌,林建银.晚期糖化终产物受体反义RNA腺相关病毒载体的构建及在肾脏系膜细胞中表达[J].免疫学杂志,2007,23(2):135-138. 被引量:2
  • 5Streck C J, Zhou J, Ng CY, et al. Long term recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in nfice with disseminated neuroblastoma[J].Am Coll Surg, 2004, 199(1): 78-86.
  • 6Tenenbaum L, Lehtonen E, Monahan PE. Evaluation of risks related to the use of adeno-associated virus-based vectors [J]. Curr Gene Ther, 2003, 3(6) : 545 - 565.
  • 7Yang ZF, Wu XB, Tsui TY, et ol. Recombination adenoassociated virus vector: is ideal for gene delivery in liver transplantation[J]. Liver Transpl, 2003, 9(4): 411- 420.
  • 8Lalani AS, Chang B, Lin J, et al. Anti tmnor efficiency of human angiostatin using liver-mediated adeno-associated virus gene therapy [J].Mol Ther, 2004, 9(1) : 56- 66.
  • 9王槐志,黎万玲,张玉君,陈志宇,朱瑾,郑平,熊燕,董家鸿.诱骗受体3对大鼠移植肝脏的保护作用[J].中华消化外科杂志,2007,6(5):356-359. 被引量:2
  • 10Raper SE, Wilson JM. Cell transplantation in liver directed gene therapy [J]. Cell Transplant, 1993, 2(5) : 381 - 400.

二级参考文献19

  • 1王儒鹏,吴军,袁军,解志杰,贺伟峰,易绍萱,张小容.核糖体失活蛋白LuffinP1的构建*[J].贵阳医学院学报,2005,30(2):103-107. 被引量:2
  • 2王儒鹏,周丽娜,吴军,贺伟峰,易绍萱,陈希伟,张小容.重组免疫毒素hIL-2-LuffinP1的构建及表达[J].第三军医大学学报,2005,27(9):828-830. 被引量:5
  • 3吴蔚,杨康,白云,王婉瑜,李军,熊刚.蛇毒因子消耗补体对大鼠同种心脏移植急性排斥反应的影响[J].免疫学杂志,2006,22(1):61-64. 被引量:6
  • 4Stern D, Yah SD, Yah SF, et al. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings[J]. Adv Drug Deliv Rev,2002, 54 (12): 1 615- 1 625.
  • 5Schmidt AM, Yan SD, Yan SF, et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses[J]. J Clin Invest, 2001, 108 (7):949 - 955.
  • 6Bierhaus A, Schiekofer S, Schwaninger M, et al.Diabetesassociated sustained activation of the transcription factor nuclear factor-κB[J]. Diabetes, 2001, 50(12): 2 792-2808.
  • 7Takeda R, Suzuki E, Satonaka H, et al. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats [ J ]. Circulation, 2005, 111 ( 11 ) : 1 398 -1406.
  • 8Wang K, Zhou Z, Zhang M, et al. Peroxisome proliferatoractivated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid arteryinjury model[J]. J Pharmacol Exp Ther, 2006, 317 (1):37 - 43.
  • 9Marx N, Walcher D, Ivanova N, et al. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products[J]. Diabetes, 2004, 53 (10): 2 662-2668.
  • 10Flyvbjerg A, Denner L, Schrijvers BF, et al. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 Diabetic mice[J]. Diabetes, 2004,53(1):166- 172.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部